Peter Meldrum, Who Lost a Fight to Patent Genes, Dies at 71
Peter D. Meldrum, who led the biotech company Myriad Genetics for 23 years, when it was at the heart of a landmark court battle involving whether two genes associated with breast cancer could be patented, died on Dec. 20 in Salt Lake City. He was 71.
A spokesman for the company said the cause was a head injury sustained when he fell while playing touch football with his grandchildren.
Mr. Meldrum and Mark Skolnick founded Myriad Genetics in 1991, and Mr. Meldrum became its chief exec...